Romanian Guidelines for Nonpharmacological Therapy of IBS

Authors

  • Dan L. Dumitrascu Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; 2nd Department of Internal Medicine, Cluj-Napoca, Romania
  • Adriana Baban Dept. of Psychology; Babes-Bolyai University, Cluj-Napoca, Romania
  • Ion Bancila Center of Gastroenterology and Hepatology Fundeni Clinical Institute, Bucharest, Romania
  • Oana Barboi Institute of Gastroenterology and Hepatology, Iasi; Grrigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Simona Bataga George E. Palade University of Medicine, Pharmacy, Sciences and Tehnology, Tg. Mures, Romania
  • Alexandra Chira Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; 2nd Department of Internal Medicine, Cluj-Napoca, Romania
  • Ioan Chirila Gheorghe T. Popa University of Medicine and Pharmacy, Iasi; Deptartment of Environmental Health, National Institute of Public Health - RCoPH Iasi, Romania
  • Cristina Cijevschi Prelipcean Institute of Gastroenterology and Hepatology, Iasi; Grrigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Lidia Ciobanu Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Anamaria Cozma-Petrut Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; Deptartment of Bromatol, Hygiene, Nutrition, Romania
  • Liliana David Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; Deptartment of Nursing, Romania
  • Mircea Diculescu Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest; Carol Davila University of Medicine and Pharmacy Bucharest, Romania
  • Daniela Dobru George E. Palade University of Medicine, Pharmacy, Sciences and Tehnology, Tg. Mures, Romania
  • Anca Dimitriu Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest; Carol Davila University of Medicine and Pharmacy Bucharest, Romania
  • Eugen Dumitru Research Center for the Morphological and Genetic Study in Malignant Pathology; Faculty of Medicine, Ovidius University Constanța, Romania
  • Mihaela Fadgyas-Stanculete Iuliu Hatieganu Univeristy of Medicine and Pharmacy, Cluj-Napoca; Department of Neurosciences, Cluj-Napoca, Romania
  • Cristian Gheorghe Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest; Carol Davila University of Medicine and Pharmacy Bucharest, Romania
  • Georgiana-Emmanuela Gilca-Blanariu Grrigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Adrian Goldis Department of Gastroenterology and Hepatology Victor Babeș University of Medicine and Pharmacy, Academy of Medicale Science, Research Center, Timișoara, Romania
  • Simona Grad Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; 2nd Department of Internal Medicine, Cluj-Napoca, Romania
  • Melania Macarie George E. Palade University of Medicine, Pharmacy, Sciences and Tehnology, Tg. Mures, Romania
  • Cristina Marica-Sabo Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; 2nd Dept. of Internal Medicine, Cluj-Napoca, Romania
  • Doina Miere Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; Deptartment of Bromatol, Hygiene, Nutrition, Romania
  • Laurentiu Nedelcu Faculty of Medicine, Transylvania University, Brasov, Romania
  • Anca Negovan George E. Palade University of Medicine, Pharmacy, Sciences and Tehnology, Tg. Mures, Romania
  • Cristina Pojoga Babes-Bolyai University, Cluj-Napoca; Regional Institute of Gastroenterol and Hepatol, Cluj-Napoca; Department of Clinical Psychology and Psychotherapy, International Institute for Advanced Study of Psychotherapy and Applied Mental Health, Cluj-Napoca; Romania
  • Andrei Vasile Pop Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; 2nd Department of Internal Medicine, Cluj-Napoca, Romania
  • Stefan-Lucian Popa Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; 2nd Department of Internal Medicine, Cluj-Napoca, Romania
  • Paul Juergen Porr Polisano MedLife Clinic, Sibiu, Romania
  • Flaviu Rusu Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; 2nd Department of Internal Medicine, Cluj-Napoca, Romania
  • Andrada Seicean Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Ioan Sporea Department of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, Academy of Medical Science, Research Center, Timișoara, Romania
  • Tudor Stroie Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest; Carol Davila University of Medicine and Pharmacy Bucharest, Romania
  • Teodora Blaga-Surdea Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca; 2nd Department of Internal Medicine, Cluj-Napoca, Romania
  • Cristina Tocia Faculty of Medicine, Ovidius University Constanța, Romania
  • Anca Trifan Institute of Gastroenterology and Hepatology, Iasi; Grrigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
  • Ciprian Brisc Faculty of Medicine and Pharmacy, University of Oradea, Romania
  • Vasile Drug Institute of Gastroenterology and Hepatology, Iasi; Grrigore T. Popa University of Medicine and Pharmacy, Iasi, Romania

DOI:

https://doi.org/10.15403/jgld-3581

Keywords:

acupuncture, alternative and complementary therapy, diet, FODMAP, irritable bowel syndrome, physical activity, probiotics

Abstract

Background and Aims: The nonpharmacological therapy in irritable bowel syndrome (IBS) is expanding rapidly. Practitioners and medical educators need to be aware of progress and changes in knowledge of this topic. The Romanian Society of Neurogastroenterology aimed to create guidelines based on best evidence on the use of nonpharmacological therapy in IBS.

Methods: A group of experts was constituted. This was divided in eleven subgroups dedicated to eleven categories of nonpharmacological therapy. The subgroups searched the literature and formulated statements and recommendations. These were submitted to vote in order to obtain consensus.

Results: The outcome of this activity is represented by the guidelines of the Romanian Society of Neurogastroenterology, presented in this paper. The recommendations are seen as complementary to the pharmacological therapy and are not intended to recommend avoiding pharmacological drugs.

Conclusions: These guidelines were elaborated by a Delphi process and represent a useful tool for physicians managing patients with IBS.

Downloads

Published

2021-06-18

How to Cite

1.
Dumitrascu DL, Baban A, Bancila I, Barboi O, Bataga S, Chira A, Chirila I, Cijevschi Prelipcean C, Ciobanu L, Cozma-Petrut A, David L, Diculescu M, Dobru D, Dimitriu A, Dumitru E, Fadgyas-Stanculete M, Gheorghe C, Gilca-Blanariu G-E, Goldis A, Grad S, Macarie M, Marica-Sabo C, Miere D, Nedelcu L, Negovan A, Pojoga C, Pop AV, Popa S-L, Porr PJ, Rusu F, Seicean A, Sporea I, Stroie T, Blaga-Surdea T, Tocia C, Trifan A, Brisc C, Drug V. Romanian Guidelines for Nonpharmacological Therapy of IBS. JGLD [Internet]. 2021 Jun. 18 [cited 2026 Aug. 11];30(2):291-306. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/3581

Issue

Vol. 30 No. 2: June 2021

Section

Romanian SNG corner